Protagonist Therapeutics Inc (PTGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 25,722 | 8,617 | 10,286 | 2,265 | 6,189 |
| Gross Profit | 25,722 | 8,617 | 10,286 | 2,265 | 6,189 |
| Operating Expenses | 46,833 | 45,633 | 44,212 | 33,147 | 30,210 |
| Operating Income | -21,111 | -37,016 | -33,926 | -30,882 | -24,021 |
| Other Income | 181 | 109 | 122 | 40 | 23 |
| Pre-tax Income | -20,930 | -36,907 | -33,804 | -30,842 | -23,998 |
| Net Income Continuous | -20,930 | -36,907 | -33,804 | -30,842 | -23,998 |
| Net Income | $-20,930 | $-36,907 | $-33,804 | $-30,842 | $-23,998 |
| EPS Basic Total Ops | -0.43 | -0.78 | -0.70 | -0.69 | -0.54 |
| EPS Basic Continuous Ops | -0.43 | -0.78 | -0.70 | -0.69 | -0.54 |
| EPS Diluted Total Ops | -0.43 | -0.78 | -0.70 | -0.69 | -0.54 |
| EPS Diluted Continuous Ops | -0.43 | -0.78 | -0.70 | -0.69 | -0.54 |
| EBITDA(a) | $-19,920 | $-35,688 | $-32,722 | $-29,781 | $-23,049 |